Literature DB >> 32002607

Dabrafenib in BRAFV600E mutant pilocytic astrocytoma.

Sora Yasri1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32002607     DOI： 10.1007/s00381-020-04527-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN： 0256-7040            Impact factor:   1.475


× No keyword cloud information.
  3 in total

1.  Dabrafenib in BRAFV600E mutant pilocytic astrocytoma in a pediatric patient.

Authors:  F Mustansir; N Mushtaq; A Darbar
Journal:  Childs Nerv Syst       Date:  2019-08-15       Impact factor: 1.475

2.  Evaluation of Genetic Variants in MIR3142HG in Susceptibility to and Prognosis of Glioma.

Authors:  Xiaoye Guo; Ming Zhang; Qi Li; Junjie Zhao; Bo Wang; Jia Wang; Ping Mao; Jinning Song
Journal:  Am J Clin Oncol       Date:  2020-01       Impact factor: 2.339

3.  TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma.

Authors:  Samantha Mascelli; Paolo Nozza; David T W Jones; Carole Colin; Angela Pistorio; Claudia Milanaccio; Marcello Ravegnani; Alessandro Consales; Olaf Witt; Giovanni Morana; Armando Cama; Valeria Capra; Roberto Biassoni; Stefan M Pfister; Dominique Figarella-Branger; Maria Luisa Garrè; Alessandro Raso
Journal:  Oncotarget       Date:  2016-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.